Substrate specificity-enabled terminal protection for direct quantification of circulating MicroRNA in patient serums

role of circulating microrna in diagnosis of acute coronary syndrome

acute coronary syndrome is the leading cause of mortality worldwide. for prompt diagnosis and management of this disease, several biomarkers have been utilized. recently microrna which are suggestive of tissue damage and some are cardiospecific are paid special attention and might help in dearly diagnosis of this disease and furthermore help in preventing the resultant mortality. in this review...

Direct Quantification of Cell-Free, Circulating DNA from Unpurified Plasma

Cell-free DNA (cfDNA) in body tissues or fluids is extensively investigated in clinical medicine and other research fields. In this article we provide a direct quantitative real-time PCR (qPCR) as a sensitive tool for the measurement of cfDNA from plasma without previous DNA extraction, which is known to be accompanied by a reduction of DNA yield. The primer sets were designed to amplify a 90 a...

New pacidamycins biosynthetically: probing N- and C-terminal substrate specificity.

Feeding phenylalanine analogues to Streptomyces coeruleorubidus reveals the remarkable steric and electronic flexibility of this biosynthetic pathway and leads to the generation of a series of new halopacidamycins.

optimizing microrna quantification in serum samples

micrornas constitute a group of small non-coding rnas that negatively regulate gene expression. aside from their contribution to biological and pathological pathways, altered expression of micrornas is reported in bio-fluid samples, such as serum. to employ serum's micrornas as potential biomarkers, it is crucial to develop an efficient method for microrna quantification, avoiding pre-analytica...

Direct Detection of Circulating MicroRNA in Cancer Patient Serum by using Protein-Facilitated Specific Enrichment and Rolling Circle Amplification